Pancreatic Cancer Research

ResearcherMarmara Üniversitesi Eğitim ve Araştırma HastanesiActive in the last 2 years

İbrahim Vedat Bayoğlu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0481-1084; OpenAlex author ID A5002010642. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 2

  1. Stage-Specific Prognostic Impact of Longitudinal Body Composition Changes in Patients with Pancreatic Ductal Adenocarcinoma Treated with FOLFIRINOX: A Dual-Coh… Last author DOI 10.3390/jcm15166282↗
  2. Second-line capecitabine and oxaliplatin combination for gemcitabine-resistant advanced pancreatic cancer. Co-author DOI 10.7314/apjcp.2014.15.17.7119↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ahmet Demirel · 1 shared paper, 2026 · strength 0.28
  2. İbrahim Yıldız · 1 shared paper, 2014 · strength 0.04
  3. Umut Varol · 1 shared paper, 2014 · strength 0.04
  4. Mustafa Oktay Tarhan · 1 shared paper, 2014 · strength 0.04
  5. Ahmet Alacacıoğlu · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.